An injectable thermosensitive hydrogel/nanomicelles composite for local chemo-immunotherapy in mouse model of melanoma.
GM-CSF
Thermosensitive hydrogel
cancer immunotherapy
combination therapy
localized delivery
low-dose chemotherapy
Journal
Journal of biomaterials applications
ISSN: 1530-8022
Titre abrégé: J Biomater Appl
Pays: England
ID NLM: 8813912
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
12
5
2022
medline:
19
8
2022
entrez:
11
5
2022
Statut:
ppublish
Résumé
Recently, cancer immunotherapy and its combination with chemotherapy has been considered to improve therapeutic efficacy with lower systemic toxicity. Here, we prepared a thermosensitive hydrogel based hyaluronic acid (HA) encapsulated with macrophage colony-stimulating factor (GM-CSF) and paclitaxel (PTX) for chemoimmunotherapy of cancer. For this purpose, the micelles were prepared with the mixture of pluronic F127 (PF127) and tocopheryl polyethylene glycol (TPGS) and loaded with PTX. In the following step, thermosensitive hydrogel using PF127 and HA was prepared and co-encapsulated with the micelles and GM-CSF. Rheological performance, friability, release patterns for PTX and GM-CSF, and stability of GM-CSF in the hydrogel were evaluated in details.
Identifiants
pubmed: 35543695
doi: 10.1177/08853282221098232
doi:
Substances chimiques
Drug Carriers
0
Hydrogels
0
Micelles
0
Poloxamer
106392-12-5
Granulocyte-Macrophage Colony-Stimulating Factor
83869-56-1
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM